123 related articles for article (PubMed ID: 17661061)
21. Traditional and emerging molecular markers in neuroblastoma prognosis: the good, the bad and the ugly.
Poremba C; Hero B; Goertz HG; Scheel C; Wai D; Schaefer KL; Christiansen H; Berthold F; Juergens H; Boecker W; Dockhorn-Dworniczak B
Klin Padiatr; 2001; 213(4):186-90. PubMed ID: 11528552
[TBL] [Abstract][Full Text] [Related]
22. Successful treatment of MYCN amplified, progressive stage 4S neuroblastoma in a neonate with hepatic artery embolization in addition to multimodality treatment.
Boztug K; Kiely E; Roebuck DJ; Gaze M; Begent J; Brock P; Michalski A
Pediatr Blood Cancer; 2006 Feb; 46(2):253-7. PubMed ID: 15926157
[TBL] [Abstract][Full Text] [Related]
23. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification.
Castle VP; Heidelberger KP; Bromberg J; Ou X; Dole M; Nuñez G
Am J Pathol; 1993 Dec; 143(6):1543-50. PubMed ID: 8256847
[TBL] [Abstract][Full Text] [Related]
24. N-myc amplification and cell proliferation rate in human neuroblastoma.
Montanaro L; Trerè D; Perri P; Pession A; Derenzini M
Eur J Histochem; 1997; 41 Suppl 2():141-2. PubMed ID: 9859821
[No Abstract] [Full Text] [Related]
25. N-myc amplification and cell proliferation rate in human neuroblastoma.
Pession A; Trerè D; Perri P; Rondelli R; Montanaro L; Mantovani W; Derenzini M; Paolucci G
J Pathol; 1997 Nov; 183(3):339-44. PubMed ID: 9422991
[TBL] [Abstract][Full Text] [Related]
26. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
Martinsson T; Sjöberg RM; Hedborg F; Kogner P
Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654
[TBL] [Abstract][Full Text] [Related]
27. Primary cervical neuroblastoma in infants.
Tai CF; Lee KS; Chen IH
J Formos Med Assoc; 1997 Jul; 96(7):561-4. PubMed ID: 9262064
[TBL] [Abstract][Full Text] [Related]
28. Genomic and metabolic aspects of neuroblastomas in children under one year of age.
Nakagawara A; Zaizen Y; Suita S
Prog Clin Biol Res; 1991; 366():115-25. PubMed ID: 2068132
[No Abstract] [Full Text] [Related]
29. Primary renal neuroblastoma--a clinical pathologic study of 8 cases.
Fan R
Am J Surg Pathol; 2012 Jan; 36(1):94-100. PubMed ID: 21989352
[TBL] [Abstract][Full Text] [Related]
30. Neuroblastomas with discordant genotype-phenotype relationships: report of four cases with MYCN amplification and favorable histology.
Nakagawa A; Matsuoka K; Okita H; Iwafuchi H; Hori H; Kumagai M
Pediatr Dev Pathol; 2011; 14(2):87-92. PubMed ID: 21288077
[TBL] [Abstract][Full Text] [Related]
31. Successful treatment of progressive stage 4s hepatic neuroblastoma in a neonate with intra-arterial chemoembolization.
Weintraub M; Bloom AI; Gross E; Revel-Vilk S; Shahroor S; Koplewitz BZ; Freeman AI
Pediatr Blood Cancer; 2004 Aug; 43(2):148-51. PubMed ID: 15236281
[TBL] [Abstract][Full Text] [Related]
32. MYCN amplification does not affect survival of neuroblastoma patients treated with autologous bone marrow transplantation.
Sansone R; Di Martino D; Lanino E; Dini G; Massimo L; Tonini GP
Bone Marrow Transplant; 1991; 7 Suppl 3():133-5. PubMed ID: 1855077
[TBL] [Abstract][Full Text] [Related]
33. Neuroblastoma with DNA amplification and rearrangement in the N-myc gene region.
Hiyama E; Hiyama K; Yokoyama T
Cancer Res; 1991 Apr; 51(7):1946-51. PubMed ID: 2004381
[TBL] [Abstract][Full Text] [Related]
34. Neuroblastoma. Pathology and biology.
Shimada H
Acta Pathol Jpn; 1992 Apr; 42(4):229-41. PubMed ID: 1609613
[No Abstract] [Full Text] [Related]
35. MYCN expression is not prognostic of adverse outcome in advanced-stage neuroblastoma with nonamplified MYCN.
Cohn SL; London WB; Huang D; Katzenstein HM; Salwen HR; Reinhart T; Madafiglio J; Marshall GM; Norris MD; Haber M
J Clin Oncol; 2000 Nov; 18(21):3604-13. PubMed ID: 11054433
[TBL] [Abstract][Full Text] [Related]
36. Flow cytometric analysis of peripheral blood and bone marrow for tumor cells in patients with neuroblastoma.
Komada Y; Zhang XL; Zhou YW; Inaba H; Deguchi T; Azuma E; Sakurai M
Cancer; 1998 Feb; 82(3):591-9. PubMed ID: 9452279
[TBL] [Abstract][Full Text] [Related]
37. Liver involvement in neuroblastoma: the Memorial Sloan-Kettering Experience supports treatment reduction in young patients.
Kushner BH; Kramer K; LaQuaglia MP; Modak S; Cheung NK
Pediatr Blood Cancer; 2006 Mar; 46(3):278-84. PubMed ID: 16124002
[TBL] [Abstract][Full Text] [Related]
38. Paratesticular neuroblastoma with N-myc activation.
Matsunaga T; Takahashi H; Ohnuma N; Tanabe M; Yoshida H; Enomoto H; Horie H; Shirasawa H; Simizu B
J Pediatr Surg; 1993 Dec; 28(12):1612-4. PubMed ID: 8301510
[TBL] [Abstract][Full Text] [Related]
39. [Comprehensive treatment of neuroblastoma in children associated with opsoclonus-myoclonus-ataxia syndrome].
Zhao W; Sun Q; Xie Y; Hua Y; Xiong H; Jia J; Lu X
Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):540-3. PubMed ID: 25224062
[TBL] [Abstract][Full Text] [Related]
40. Presacral cystic neuroblastoma: case report and review of the literature.
D'Alessio A; Piro E; Beretta F; Abati L; Brugnoni M; Assi A; Luksch R
J Pediatr Hematol Oncol; 2006 Aug; 28(8):534-6. PubMed ID: 16912595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
